2024). In another study that compares Aβ and p‐tau levels between healthy controls and AD patients, Singh et al. (2024) demonstrated that the concentration of EVs is significantly greater in individuals with AD than in healthy control subjects. Notably, the expression of Aβ(1–42) within these EVs is markedly increased in AD cases compared to healthy controls. Here, MAPT is linked to Alzheimer disease.